The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 23, 2019

Filed:

Feb. 17, 2017
Applicant:

Laboratory Corporation of America Holdings, Burlington, NC (US);

Inventors:

Wei Huang, Foster City, CA (US);

Signe Fransen, San Francisco, CA (US);

Christos Petropoulos, Half Moon Bay, CA (US);

Jonathan Toma, San Francisco, CA (US);

Jeannette Whitcomb, San Mateo, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/70 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/703 (2013.01); G01N 33/56988 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/16 (2013.01); G01N 2333/162 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention provides methods and compositions for determining whether a subject would benefit from co-receptor inhibitor therapy. In certain aspects, the methods can be used to determine whether a subject infected with a dual-mixed tropic population of HIV would benefit from CCCR5-inhibitor therapy or CXCR4-inhibitor therapy, the methods comprising determining whether the HIV population is a homogeneous or heterogeneous population of HIV, wherein the nature of the homogenous or heterogenous population of HIV indicates whether the patient would benefit from co-receptor inhibitor therapy.


Find Patent Forward Citations

Loading…